VP-16-213 (ETOPOSIDE) - THE MANDRAKE ROOT FROM ISSYK-KUL

被引：100

作者：

VOGELZANG, NJ ^{[1
]}

RAGHAVAN, D ^{[1
]}

KENNEDY, BJ ^{[1
]}

机构：

[1] MASONIC CANC CTR, MINNEAPOLIS, MN USA

来源：

关键词：

D O I：

10.1016/0002-9343(82)90600-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：136 / 144

页数：9

共 109 条

[1] ABELOFF MD, 1979, CANCER TREAT REP, V63, P519
[2] AHMANN DL, 1976, CANCER TREAT REP, V60, P1681
[3] AHMANN DL, 1976, CANCER TREAT REP, V60, P633
[4] AISNER J, 1980, CANCER, V46, P2543, DOI 10.1002/1097-0142(19801215)46:12<2543::AID-CNCR2820461202>3.0.CO
[5] 2-4
[6] ACTIVITY OF THE EPIPODOPHYLLOTOXIN VP-16 IN THE TREATMENT OF COMBINATION CHEMOTHERAPY-RESISTANT NON-HODGKIN LYMPHOMA
BENDER, RA
ANDERSON, T
FISHER, RI
YOUNG, RC
[J]. AMERICAN JOURNAL OF HEMATOLOGY, 1978, 5 (03) : 203 - 209
[7] Bentley R., 1861, PHARMACEUTI CAL J T, V3, P456
[8] THE TREATMENT OF ADVANCED TESTICULAR-CARCINOMA WITH HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS MARROW SUPPORT
BLIJHAM, G
SPITZER, G
LITAM, J
ZANDER, AR
VERMA, DS
VELLEKOOP, L
SAMUELS, ML
MCCREDIE, KB
DICKE, KA
[J]. EUROPEAN JOURNAL OF CANCER, 1981, 17 (04) : 433 - 441
[9] BRITELL JC, 1979, CANCER TREAT REP, V63, P2130
[10] TREATMENT OF BRONCHOGENIC CARCINOMA .2. SMALL CELL
BRODER, LE
COHEN, MH
SELAWRY, OS
[J]. CANCER TREATMENT REVIEWS, 1977, 4 (04) : 219 - 260